Samsung Biologics: I Dipped a Toe In, Not the Whole Foot
Today I put Samsung Biologics in the basket. The macro regime reads neutral, which means it was neither a day to flip the table nor a day to bolt the door, so I added just one name, quietly. The positions I already hold stay as they are, with no selling and no adding.
I knew the price felt heavy, and left the door open anyway
Samsung Biologics comes in at grade B, a composite 56.2. In plain words: a good company, but the price and the mood aren't comfortable yet, so I buy it without hurrying. Break the score apart and the reason is right there.
| Item | Score |
|---|---|
| Financial strength | 85 |
| Valuation | 40 |
| Sentiment | 42 |
| Composite | 56.2 (grade B) |
Financial strength at 85 is very strong, so I have no doubt the foundation is solid. But valuation at 40 and sentiment at 42 hold it back. So I didn't pile in all at once. I just dipped a toe in first.
Two names I'm only calling out for now
LS ELECTRIC and Samsung Electro-Mechanics stay on my watch list again today, because I don't think the case for buying them has filled in enough yet. What I'll check in the next entry is whether their composite scores climb past the B-grade threshold the way Samsung Biologics did, and above all whether valuation and sentiment fill in. Until then, I only follow them with my eyes.
So my view of the portfolio is calm. I took an 85-point financial name at a cautious 56.2, which wasn't a reckless day. If valuation at 40 rises or sentiment at 42 loosens, I'll think again, but until then I hold quietly and don't rush. This is a paper record, nothing more.